We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,324 results
  1. Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis

    Idiopathic pulmonary fibrosis (IPF) is a highly debilitating and fatal chronic lung disease that is difficult to cure clinically. IPF is...

    Meiling Zheng, Kai Liu, ... Guanghao Wu in Journal of Nanobiotechnology
    Article Open access 03 January 2024
  2. Using the Bleomycin-Induced Model of Fibrosis to Study the Contribution of CCN Proteins to Scleroderma Fibrosis

    Approximately 45% of the deaths in the developed world result from conditions with a fibrotic component. Although no specific, focused anti-fibrotic...
    Alexander Peidl, John Nguyen, ... Andrew Leask in CCN Proteins
    Protocol 2023
  3. miR-23b-3p Ameliorates LPS-Induced Pulmonary Fibrosis by Inhibiting EndMT via DPP4 Inhibition

    Acute respiratory distress syndrome is a disease triggered by severe pulmonary and systemic inflammation that may lead to fibrosis and the decline of...

    Linlin Yue, Feng Chen, ... Hongquan Zhu in Molecular Biotechnology
    Article Open access 27 December 2023
  4. Single-cell RNA transcriptomic reveal the mechanism of MSC derived small extracellular vesicles against DKD fibrosis

    Diabetic kidney disease (DKD), a chronic kidney disease, is characterized by progressive fibrosis caused due to persistent hyperglycemia. The...

    Cheng Ji, Jiahui Zhang, ... Hui Qian in Journal of Nanobiotechnology
    Article Open access 18 June 2024
  5. Guardians Turned Culprits: NETosis and Its Influence on Pulmonary Fibrosis Development

    Idiopathic pulmonary fibrosis (IPF) is a debilitating, life-threatening irreversible lung disease characterized by the excessive accumulation of...

    Aleena Varughese, Akarsha Balnadupete, ... Yashodhar Bhandary in Molecular Biotechnology
    Article 08 May 2024
  6. Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects

    It is reported that pulmonary fibrosis has become one of the major long-term complications of COVID-19, even in asymptomatic individuals. Currently,...

    Qianyu Wan, **nrui Zhang, ... Xuanrong Sun in Journal of Nanobiotechnology
    Article Open access 08 July 2023
  7. Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan

    Purpose

    Studies evaluating food insecurity and metabolic dysfunction-associated steatotic liver disease (MASLD) and significant hepatic fibrosis are...

    Donghee Kim, Brandon J. Perumpail, ... Aijaz Ahmed in European Journal of Nutrition
    Article 23 January 2024
  8. CircUTRN24/miR-483-3p/IGF-1 Regulates Autophagy Mediated Liver Fibrosis in Biliary Atresia

    Biliary atresia (BA) is a rare neonatal cholestatic disease that presents with a marked bile duct reaction and rapid fibrotic development. Our...

    Dong Liu, Zhouguang Wu, ... Bin Wang in Molecular Biotechnology
    Article 27 June 2023
  9. Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation

    Background

    Renal fibrosis is a progressive process associated with chronic kidney disease (CKD), contributing to impaired kidney function. Active...

    Yu Hou, Lin Zhu, ... Yinghui Wei in Journal of Nanobiotechnology
    Article Open access 01 June 2024
  10. Bidirectional negative feedback actions of DNMT3A and miR-145 in regulating autophagy in cardiac fibroblasts and affecting myocardial fibrosis

    Epigenetic regulation has crucial implications for myocardial fibrosis. It has been reported that autophagy, regulated by miR-145, is implicated in...

    Shucan Xu, Yonglin Zhang, ... Aijun Liu in Journal of Bioenergetics and Biomembranes
    Article 23 August 2023
  11. MAP3K19 Promotes the Progression of Tuberculosis-Induced Pulmonary Fibrosis Through Activation of the TGF-β/Smad2 Signaling Pathway

    Tuberculosis-induced pulmonary fibrosis (PF) is a chronic, irreversible interstitial lung disease, which severely affects lung ventilation and air...

    Yu **a, Haiyue Wang, ... Feng Sun in Molecular Biotechnology
    Article 31 October 2023
  12. Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway

    All chronic renal disorders eventually lead to renal interstitial fibrosis (RIF). Chronic inflammation and pro-fibrotic substances are familiar...

    Ziqing Yu, Wen He, Weiwu Shi in Applied Biological Chemistry
    Article Open access 24 January 2024
  13. Anti-Liver Fibrosis Role of miRNA-96-5p via Targeting FN1 and Inhibiting ECM-Receptor Interaction Pathway

    The aberrant expression of mRNAs participates in the pathogenesis of hepatic fibrosis. However, the precise mechanisms regulated by microRNAs...

    Yong Zhang, Tengfei Gu, ... **nguo Zhu in Applied Biochemistry and Biotechnology
    Article 21 March 2023
  14. Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway

    Lysyl oxidase-like 2 (LOXL2) is an extracellular copper-dependent enzyme that plays a central role in fibrosis by catalyzing the crosslinking and...

    Fang Cheng, Fuji Yang, ... Yongmin Yan in Journal of Nanobiotechnology
    Article Open access 16 June 2023
  15. Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects

    Pulmonary fibrosis (PF) threatens millions of people worldwide with its irreversible progression. Although the underlying pathogenesis of PF is not...

    Meiling Zheng, Wei Zhu, ... Cuiling Feng in Journal of Nanobiotechnology
    Article Open access 29 March 2024
  16. Therapeutic effects of TMF and catechol in pulmonary fibrosis: in vitro and in vivo analysis

    Idiopathic pulmonary fibrosis is a fatal lung disorder characterized by abnormal deposition of extracellular matrix (ECM), which is secreted by...

    **-Hyuk Choi, Youngmee Kim, Moonjae Cho in Applied Biological Chemistry
    Article Open access 01 February 2023
  17. Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis

    Background

    Hypertrophic scars (HS) affect millions of people each year and require better treatment strategies. Bacterial extracellular vesicles (EVs)...

    Fu Han, Kejia Wang, ... Gaofeng Wu in Journal of Nanobiotechnology
    Article Open access 28 March 2023
  18. Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease

    To determine their involvement in the onset of the disease, we investigated the changing levels of liver fibrosis-related proteins, namely, type-I...

    Liyun Wang, Kahua Liu, ... Keshu Xu in Applied Biochemistry and Biotechnology
    Article 30 August 2023
  19. P65 mediated UBR4 in exosomes derived from menstrual blood stromal cells to reduce endometrial fibrosis by regulating YAP Ubiquitination

    Background

    Intrauterine adhesion (IUA) is a recurrent and refractory reproductive dysfunction disorder for which menstrual blood-derived stromal cells...

    Jiarui Qi, Xudong Zhang, ... Jichun Tan in Journal of Nanobiotechnology
    Article Open access 29 August 2023
  20. Weight regain, but not weight loss exacerbates hepatic fibrosis during multiple weight cycling events in male mice

    Purpose

    Weight cycling is a phenomenon characterized by fluctuating body weight that is commonly observed in individuals employing intentional weight...

    Chun‐Hsien Chiang, Ting-Rui Zhang, ... Ching‐Yi Chen in European Journal of Nutrition
    Article 24 January 2024
Did you find what you were looking for? Share feedback.